EVT.DE Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 18:35):

Stats
Dzisiejszy wolumen	1.94M
Średni wolumen	1.30M
Kapitalizacja rynkowa	1.73B
EPS	€-0.220 ( 2023-11-08 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-9.48
ATR14	€0.0130 (0.13%)

Wolumen Korelacja

Długi: -0.05 (neutral)

Krótki: 0.32 (neutral)

Signal:(40.637) Neutral

Evotec SE Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evotec SE Korelacja - Waluta/Towar

0.53
( weak )

0.00
( neutral )

0.20
( neutral )

Evotec SE Finanse

Annual	2022
Przychody:	€751.45M
Zysk brutto:	€174.07M (23.16 %)
EPS:	€-0.990

FY	2022
Przychody:	€751.45M
Zysk brutto:	€174.07M (23.16 %)
EPS:	€-0.990

FY	2021
Przychody:	€618.03M
Zysk brutto:	€151.54M (24.52 %)
EPS:	€1.300

FY	2020
Przychody:	€500.92M
Zysk brutto:	€125.74M (25.10 %)
EPS:	€0.0400

Financial Reports:

No articles found.

Evotec SE

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer AG; Lilly; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.